Similarly, the in vitro treatment of HUVECs with serum from SLE and RA patients before RTX therapy promoted the increased expression of inflammatory mediators such as VEGF, IL‐8, ICAM‐1 and endothelial nitric oxide synthase. Here, VEGFA is linked to systemic lupus erythematosus.